by Administrators Qynapse | Apr 26, 2021 | News
BOSTON, MA, April 26, 2021 – QYNAPSE Inc., a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to participate in the Sachs 4th Annual Neuroscience Innovation Forum (#Sachs_NIF) on April 28-30, 2021,...
by Administrators Qynapse | Dec 30, 2020 | News
New Global Industry Coalition That Aims to Dramatically Increase Access for All Patients Populations in Clinical Trials and Research Paris, France and Boston, MA, December 30, 2020 – QYNAPSE Inc. joins a historic alliance of fifty life sciences and healthcare...
by Administrators Qynapse | Nov 24, 2020 | News
Paris, FRANCE and Boston, MA, November 24, 2020 / PRNewswire / – QYNAPSE Inc. a medical technology company commercializing the most advanced artificial intelligence neuroimaging platform, is pleased to sponsor the 106th Radiology Society of North America (RSNA) Annual...
by Administrators Qynapse | Nov 12, 2020 | News
Paris, France and Boston, MA, November 12th, 2020 – QYNAPSE SAS, a medical technology company commercializing the most advanced neuroimaging AI platform, appoints Matt Ullum, CPA, MBA as Chief Commercial Officer. In his new role, Matt assumes overall responsibility...
by Administrators Qynapse | Nov 3, 2020 | News
Paris, France and Boston, MA, November 3rd, 2020 – QYNAPSE SAS, a medical technology company, will present results on QyPredict®, an AI prediction technology for patient selection in Alzheimer’s clinical trials, at the 13th Clinical Trials on Alzheimer’s Disease...